CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway

Abstract Objective This study aimed to explore the effect of CD276 expression on the sunitinib sensitivity of clear cell renal cell carcinoma (ccRCC) cell and animal models and the potential mechanisms involved. Methods CD276 expression levels of ccRCC and normal samples were analyzed via online dat...

詳細記述

書誌詳細
出版年:BMC Cancer
主要な著者: Zhi-yu Zhang, Jian-hao Xu, Jiang-lei Zhang, Yu-xin Lin, Jun Ou-Yang
フォーマット: 論文
言語:英語
出版事項: BMC 2024-05-01
主題:
オンライン・アクセス:https://doi.org/10.1186/s12885-024-12402-7